From: Clinical relevance of serum lipids in the carcinogenesis of oral squamous cell carcinoma
 | Control | OSCC | OPMD | P1 | P2 | P3 |
---|---|---|---|---|---|---|
TC (mmol/L) | 4.24 ± 2.69 | 4.31 ± 1.37 | 4.45 ± 1.20 | 0.766 | 0.104 | 0.400 |
TG (mmol/L) | 1.46 ± 2.83 | 1.62 ± 1.37 | 1.50 ± 1.32 | 0.260 | 0.927 | 0.551 |
HDL-C (mmol/L) | 0.85 ± 1.13 | 0.82 ± 0.55 | 1.12 ± 0.48 | 0.757 | < 0.01* | < 0.01* |
LDL-C (mmol/L) | 2.64 ± 2.12 | 2.77 ± 1.09 | 2.56 ± 0.96 | 0.234 | 0.607 | 0.052 |
Apo-A (g/L) | 1.27 ± 0.71 | 1.23 ± 0.41 | 1.40 ± 0.36 | 0.240 | < 0.01* | < 0.01* |
Apo-B (g/L) | 0.91 ± 0.85 | 0.88 ± 0.41 | 0.98 ± 0.48 | 0.544 | 0.114 | 0.015* |
Lpa (mg/L) | 175.83 ± 720.54 | 178.71 ± 358.96 | 154.01 ± 333.67 | 0.993 | 0.711 | 0.682 |
BMI (kg/m2) | 22.79 ± 9.48 | 22.48 ± 4.65 | 23.28 ± 4.33 | 0.641 | 0.363 | 0.097 |